The efficacy and safety of Janus kinase inhibitors in patients with atopic dermatitis: A systematic review and meta-analysis

Affiliations

• ¹ Department of Dermatology, Ministry of Education Key Laboratory of Child Development and Disorders, National Clinical Research Center for Child Health and Disorders, China International Science and Technology Cooperation Base of Child Development and Critical Disorders, Children's Hospital of Chongqing Medical University, China; Chongqing Key Laboratory of Pediatrics, Chongqing, China.
• ² Department of Spine Surgery, The Third Xiangya Hospital of Central South University, Changsha, Hunan, China.
• ³ Department of Respirology & Allergy, Third Affiliated Hospital of Shenzhen University, China.
• ⁴ Department of Respiratory Medicine, Xiangya Hospital, Central South University, Changsha, Hunan, China.
• ⁵ Department of Dermatology, Ministry of Education Key Laboratory of Child Development and Disorders, National Clinical Research Center for Child Health and Disorders, China International Science and Technology Cooperation Base of Child Development and Critical Disorders, Children's Hospital of Chongqing Medical University, China; Chongqing Key Laboratory of Pediatrics, Chongqing, China. Electronic address: xyluo@hospital.cqmu.edu.cn.
• ⁶ Department of Dermatology, Ministry of Education Key Laboratory of Child Development and Disorders, National Clinical Research Center for Child Health and Disorders, China International Science and Technology Cooperation Base of Child Development and Critical Disorders, Children's Hospital of Chongqing Medical University, China; Chongqing Key Laboratory of Pediatrics, Chongqing, China. Electronic address: huawang@hospital.cqmu.edu.cn.